Resultados da pesquisa - Inge G.P. Geelen
- A mostrar 1 - 2 resultados de 2
-
1
Treatment outcome in a population-based, ‘real-world’ cohort of patients with chronic myeloid leukemia Por Inge G.P. Geelen, Noortje Thielen, Jeroen J.W.M. Janssen, Mels Hoogendoorn, Tanja J.A. Roosma, Sten P. Willemsen, Otto Visser, Jan J. Cornelissen, Peter E. Westerweel
Publicado em 2017Artigo -
2
Treatment‐Free Remission Outcomes in a <i><scp>BCR</scp>::<scp>ABL1</scp></i> Digital <scp>PCR</scp> Selected Clinical Cohort of <scp>CML</scp> Patients Por Camille Kockerols, Peter J.M. Valk, Pauline Hogenbirk, Inge G.P. Geelen, Nicole M. A. Blijlevens, Jeroen J.W.M. Janssen, Mels Hoogendoorn, Sabina Kersting, S. K. Klein, Laura G.M. Daenen, Marjolein L. Donker, Peter te Boekhorst, K.-S. Jie, Maarten F. Corsten, Marjan Cruijsen, Henriëtte Levenga, W. M. Smit, Mark‐David Levin, Eva de Jongh, S. de Jonge, André J. Vlot, M. Durian, Jaap Jan Zwaginga, M. Mohlmann, T. J. Wustman, R. Blommers, Jan J. Cornelissen, Peter E. Westerweel
Publicado em 2025Artigo
Ferramentas de pesquisa:
Assuntos relacionados
Cohort
Imatinib
Internal medicine
Medicine
Myeloid leukemia
Oncology
Receptor
Biology
Cancer
Clinical endpoint
Clinical trial
Cumulative incidence
Cutoff
Dasatinib
Digital polymerase chain reaction
Discontinuation
Environmental health
Gene
Genetics
Imatinib mesylate
Immunology
Nilotinib
Physics
Polymerase chain reaction
Population
Quantum mechanics
Tyrosine kinase
Tyrosine-kinase inhibitor
breakpoint cluster region